DRUG-DELIVERY; CO-DELIVERY; PHASE-II; FORMULATION; EFFICACY; CANCER; SIRNA; TRANSFECTION; HUMANS; SERUM
MOLECULAR PHARMACEUTICS, v.12, no.4, pp.1230 - 1241
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.